Financial Performance - Total operating revenue for 2025 reached CNY 309,164,765.32, an increase of 11.58% compared to CNY 277,091,212.17 in the previous year[3] - Operating profit decreased by 57.70% to CNY 18,591,131.28 from CNY 43,955,562.57 year-on-year[3] - Total profit fell by 59.52% to CNY 17,554,079.00 from CNY 43,359,554.40 in the previous year[3] - Net profit attributable to shareholders of the parent company decreased by 69.80% to CNY 11,865,168.46 from CNY 39,283,401.38 year-on-year[3] - Net profit attributable to shareholders of the parent company after deducting non-recurring gains and losses dropped by 80.21% to CNY 4,855,687.46 from CNY 24,531,062.63[3] - Basic earnings per share decreased by 69.53% to CNY 0.10 from CNY 0.32 in the previous year[3] R&D Investment - The company increased its R&D investment and launched the Shanghai R&D center project to enhance core product competitiveness[6] - The decline in net profit was influenced by increased R&D expenses and the lack of scale in new business development[6][8] Assets and Equity - Total assets at the end of the reporting period were CNY 1,358,066,689.33, a slight increase of 0.26% from CNY 1,354,484,847.76 at the beginning of the period[3] - Shareholders' equity attributable to the parent company increased by 1.01% to CNY 1,184,019,145.32 from CNY 1,172,153,976.86[4]
中研股份(688716) - 2025 Q4 - 年度业绩